FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and are intended for treating urinary bladder cancer. Apaziquone is applied. Medication is introduced intravesically during 6 hours after transurethral resection.
EFFECT: invention makes it possible to achieve re-epithelisation after TUR in patients with absence of systemic side effects.
15 cl, 4 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| INTRAVESICAL APAZIQUONE INJECTION AFTER TRANSURETHRAL RESECTION FOR CANCER TREATMENT | 2012 |
|
RU2623142C2 |
| COMPOSITIONS AND METHODS OF TREATING BLADDER CANCER | 2008 |
|
RU2542449C2 |
| METHOD OF TREATING BLADDER CANCER | 2014 |
|
RU2581946C2 |
| METHODS OF TREATMENT OF TUMOR METASTASIS | 2018 |
|
RU2799546C2 |
| METHOD OF COMPLEX TREATMENT AND PREVENTION OF RECURRENCES OF MUSCULAR-NON-INVASIVE FORMS OF URINARY BLADDER CANCER | 2013 |
|
RU2560314C2 |
| METHOD OF TREATMENT OF SUPERFICIAL CANCER OF BLADDER | 2007 |
|
RU2350338C2 |
| METHOD OF TREATING MALIGNANT BLADDER TUMOURS | 2009 |
|
RU2405601C1 |
| METHOD FOR TREATING THE CASES OF URINARY BLADDER CANCER | 2005 |
|
RU2276605C1 |
| METHOD FOR TREATMENT OF CANCER OF LOWER PATHWAY UROTHELIUM | 2017 |
|
RU2764747C2 |
| METHOD OF PHOTODYNAMIC THERAPY (PDT) OF BLADDER CANCER | 2016 |
|
RU2745194C2 |
